POLX vs. RUA, MHC, SUN, BELL, DEMG, IHC, IUG, GDR, IMM, and MXC
Should you be buying Polarean Imaging stock or one of its competitors? The main competitors of Polarean Imaging include RUA Life Sciences (RUA), MyHealthChecked (MHC), Surgical Innovations Group (SUN), Belluscura (BELL), Deltex Medical Group (DEMG), Inspiration Healthcare Group (IHC), Intelligent Ultrasound Group (IUG), genedrive (GDR), ImmuPharma (IMM), and Argent BioPharma (MXC). These companies are all part of the "medical" sector.
RUA Life Sciences (LON:RUA) and Polarean Imaging (LON:POLX) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their institutional ownership, risk, media sentiment, valuation, earnings, community ranking, analyst recommendations, profitability and dividends.
Polarean Imaging received 23 more outperform votes than RUA Life Sciences when rated by MarketBeat users. Likewise, 67.65% of users gave Polarean Imaging an outperform vote while only 0.00% of users gave RUA Life Sciences an outperform vote.
RUA Life Sciences has higher revenue and earnings than Polarean Imaging. RUA Life Sciences is trading at a lower price-to-earnings ratio than Polarean Imaging, indicating that it is currently the more affordable of the two stocks.
Polarean Imaging has a net margin of 0.00% compared to Polarean Imaging's net margin of -100.05%. Polarean Imaging's return on equity of -40.56% beat RUA Life Sciences' return on equity.
20.7% of RUA Life Sciences shares are held by institutional investors. Comparatively, 23.4% of Polarean Imaging shares are held by institutional investors. 18.8% of RUA Life Sciences shares are held by company insiders. Comparatively, 28.0% of Polarean Imaging shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.
RUA Life Sciences has a beta of 1.28, indicating that its stock price is 28% more volatile than the S&P 500. Comparatively, Polarean Imaging has a beta of 0.65, indicating that its stock price is 35% less volatile than the S&P 500.
In the previous week, RUA Life Sciences had 1 more articles in the media than Polarean Imaging. MarketBeat recorded 1 mentions for RUA Life Sciences and 0 mentions for Polarean Imaging. Polarean Imaging's average media sentiment score of 0.00 equaled RUA Life Sciences'average media sentiment score.
Summary
Polarean Imaging beats RUA Life Sciences on 8 of the 14 factors compared between the two stocks.
Get Polarean Imaging News Delivered to You Automatically
Sign up to receive the latest news and ratings for POLX and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Polarean Imaging Competitors List
Related Companies and Tools
